Answers are grounded in this paper and cite their sources.
OBJECTIVE: Marginal donor livers (MDLs) are highly susceptible to ischemia-reperfusion injury (IRI), in which ferroptosis, an iron-dependent form of cell death, plays a key role. We tested the hypothesis that iron chelation with deferoxamine (DFO) attenuates ferroptosis and reduces injury in human MDLs using ex vivo perfusion. METHODS: Split lobes from six human MDLs were perfused utilizing the novel Perfusion Regulated Organ Therapeutics with Enhanced Controlled Testing (PROTECT) system, with one lobe receiving DFO (0.6 mmol/L; single or dual dosing) and the contralateral lobe serving as control. Outcomes included iron content, ferroptosis-related gene and protein expression, apoptosis (TUNEL), lipid peroxidation (malondialdehyde [MDA]), and hepatocellular injury. RESULTS: DFO achieved iron chelation, with ≥20% reduction in iron versus controls. Chelated lobes demonstrated downregulation of ferroptosis-related genes including HIF-1α, IREB2, RPL8, FTH1, ACSF2, ATP5G3 (multiple targets p < 0.0001) and reduced HIF-1α protein expression (p = 0.0040). This molecular shift translated into reduced tissue injury, with fewer apoptotic cells on TUNEL staining (p = 0.0283) and decreased lipid peroxidation. Aspartate aminotransferase trended lower with DFO but did not reach significance (p = 0.0727). In contrast, non-chelated lobes (n = 8) demonstrated persistent iron accumulation, upregulation of ferroptosis pathways, and increased apoptosis and oxidative stress. Stratified analysis confirmed that iron reduction was associated with suppression of ferroptosis gene expression (multiple targets, p = 0.0040-0.0485) and lower injury markers. Dual dosing improved chelation efficacy (2/2 vs. 2/4 single dose), and protective effects were observed in steatotic livers. CONCLUSIONS: DFO-mediated iron chelation reduces ferroptosis signaling and early IRI in human MDLs. Targeting iron-dependent pathways may improve viability and utilization of high-risk donor livers.
No takes yet. Share an insight, caveat, or question.
Nazzal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: